Prevalence and mechanisms of macrolide resistance in clinical isolates of group A streptococci from Ontario, Canada

Antimicrobial Agents and Chemotherapy

Volumn 43, Issue 9, 1999, Pages 2144-2147

  De Azavedo, J C S ^a,b,c   Yeung, R H ^b   Bast, D J ^a,b   Duncan, C L ^a   Borgia, S B ^a   Low, D E ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; QUINUPRISTIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANADA; CONTROLLED STUDY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; STRAIN DIFFERENCE; STREPTOCOCCUS GROUP A;

EID: 0032824391     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.43.9.2144     Document Type: Article

References (30)

1. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. 1987. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
2. Clancy, J., J. Petitpas, F. Dib-Hajj, W. Yuan, M. Cronan, A. V. Kamath, J. Bergeron, and J. A. Retsema. 1996. Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from Streptococcus pyogenes. Mol. Microbiol. 22:867-879.
3. Cocuzza, C. E., R. Mattina, A. Mazzariol, G. Orefici, R. Rescaldani, A. Primavera, S. Bramati, G. Masera, F. Parizzi, G. Cornaglia, and R. Fontana. 1997. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngotonsillitis: an epidemiological and molecular study. Microb. Drug Resist. 3:371-378.
4. Coonan, K. M., and E. L. Kaplan. 1994. In vitro susceptibility of recent North American group A streptococcal isolates to eleven oral antibiotics. Pediatr. Infect. Dis. J. 13:630-635.
5. Courvalin, P., and C. Carlier. 1986. Transposable multiple antibiotic resistance in Streptococcus pneumoniae. Mol. Gen. Genet. 205:291-297.
6. Courvalin, P., H. Ounissi, and M. Arthur. 1985. Multiplicity of macrolide-lincosamide-streptogramin antibiotic resistance determinants. J. Antimicrob. Chemother. 16(Suppl. A):91-100.
7. Dixon, J. M., and A. E. Lipinski. 1974. Infections with beta-hemolytic Streptococcus resistant to lincomycin and erythromycin and observations on zonal-pattern resistance to lincomycin. J. Infect. Dis. 130:351-356.
8. Fujita, K., K. Murono, M. Yoshikawa, and T. Murai. 1994. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr. Infect. Dis. J. 13:1075-1078.
9. Goossens, H., S. Chapelle, M. Hauchecorne, M. Wijdooghe, and P. Descheemaeker. 1998. Characterization of macrolide resistance among group A Streptococcus in Belgium, abstr. C-14, p. 72. In Abstracts of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
10. Griffith, F. 1934. Serological classification of Streptococcus pyogenes. J. Hyg. (London) 34:542-584. (Abstract.)
11. Horn, D. L., J. B. Zabriskie, R. Austrian, P. P. Cleary, J. J. Ferretti, V. A. Fischetti, E. Gotschlich, E. L. Kaplan, M. McCarty, S. M. Opal, R. B. Roberts, A. Tomasz, and Y. Wachtfogel. 1998. Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin. Infect. Dis. 26:1341-1345.
12. Hsueh, P. R., H. M. Chen, A. H. Huang, and J. J. Wu. 1995. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39:2239-2242.
13. Jasir, A., and C. Schalen. 1998. Survey of macrolide resistance phenotypes in Swedish clinical isolates of Streptococcus pyogenes. J. Antimicrob. Chemother. 41:135-137.
14. Johnston, N. J., J. C. De Azavedo, J. D. Kellner, and D. E. Low. 1998. Prevalence and characterization of the mechanisms of macrolide, lincosamide, and streptogramin resistance in isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42:2425-2426.
15. Kataja, J., P. Huovinen, A. Muotiala, J. Vuopio-Varkila, A. Efstratiou, G. Hallas, the Finnish Study Group for Antimicrobial Resistance, and H. Seppala. 1998. Clonal spread of group A streptococcus with the new type of erythromycin resistance. J. Infect. Dis. 177:786-789.
16. Kataja, J., P. Huovinen, M. Skurnik, the Finnish Study Group for Antimicrobial Resistance, and H. Seppala. 1999. Erythromycin resistance genes in group A streptococci in Finland. Antimicrob. Agents Chemother. 43:48-52.
17. Leclercq, R., and P. Courvalin. 1991. Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modification. Antimicrob. Agents Chemother. 35:1267-1272.
18. Lopardo, H. A., M. E. Venuta, P. Vidal, L. Rosaenz, C. Corthey, A. Farinati, E. Couto, B. Sarachian, M. Sparo, S. Kaufman, C. A. De Mier, L. Gubbay, V. Scilingo, and P. Villaverde. 1997. Argentinian collaborative study on prevalence of erythromycin and penicillin susceptibility in Streptococcus pyogenes. The Argentinian Streptococcus Study Group. Diagn. Microbiol. Infect. Dis. 29:29-32.
19. Maruyama, S., H. Yoshioka, K. Fujita, M. Takimoto, and Y. Satake. 1979. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am. J. Dis. Child. 133:1143-1145.
20. Murray, B. E., K. V. Singh, J. D. Heath, B. R. Sharma, and G. M. Weinstock. 1990. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J. Clin. Microbiol. 28:2059-2063.
21. National Committee for Clinical Laboratory Standards. 1998. Performance standards for antimicrobial susceptibility testing. M100-S8. National Committee for Clinical Laboratory Standards, Villanova, Pa.
22. Perez-Trallero, E., M. Urbieta, M. Montes, I. Ayestaran, and J. M. Marimon. 1998. Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain. Eur. J. Clin. Microbiol. Infect. Dis. 17:25-31.
23. Phillips, G., D. Parratt, G. V. Orange, I. Harper, H. McEwan, and N. Young. 1990. Erythromycin-resistant Streptococcus pyogenes. J. Antimicrob. Chemother. 25:723-724. (Letter.)
24. Seppala, H., T. Klaukka, J. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, and P. Huovinen. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441-46.
25. Seppala, H., M. Skurnik, H. Soini, M. C. Roberts, and P. Huovinen. 1998. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 42:257-262.
26. Smith, A. M., K. P. Klugman, T. J. Coffey, and B. G. Spratt. 1993. Genetic diversity of penicillin-binding protein 2B and 2X genes from Streptococcus pneumoniae in South Africa. Antimicrob. Agents Chemother. 37:1938-1944.
27. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin-resistant determinants by PCR. Antimicrob. Agents Chemother. 40:2562-2566.
28. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
29. Weisblum, B. 1985. Inducible resistance to macrolides, lincosamides and streptogramin type B antibiotics: the resistance phenotype, its biological diversity, and structural elements that regulate expression - a review. J. Antimicrob. Chemother. 16(Suppl. A):63-90.
30. Widdowson, C. A., and K. P. Klugman. 1998. Emergence of the M phenotype of erythromycin-resistant pneumococci in South Africa. Emerg. Infect. Dis. 4:277-281.